Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.58 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.58 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.49 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.47 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10066946 | 0.79 | METAP2 (0.44) | IDO1ENPP2NOTUMNISCH | |
| SCHEMBL8136764 | 0.78 | ENPP2 (0.55) | IDO1ENPP2NOTUMEGFRFGFR1 | |
| SCHEMBL16168686 | 0.77 | IDO1 (0.64) | IDO1ENPP2NOTUMNISCHEGFR | |
| SCHEMBL22501795 | 0.75 | ENPP2 (0.52) | IDO1ENPP2MRGPRX4EGFR | |
| SCHEMBL5378711 | 0.74 | MAPK8 (0.54) | IDO1ENPP2MRGPRX4EGFRFGFR1 | |
| SCHEMBL1334565 | 0.74 | IDO1 (1.00) | IDO1ENPP2MRGPRX4NOTUM | |
| SCHEMBL1985682 | 0.74 | IDO1 (0.64) | IDO1ENPP2MRGPRX4EGFR | |
| SCHEMBL3080603 | 0.74 | ENPP2 (1.00) | IDO1ENPP2 | |
| SCHEMBL2659146 | 0.74 | IDO1 (0.64) | IDO1ENPP2 | |
| SCHEMBL179125 | 0.73 | NISCH (0.55) | IDO1MRGPRX4NOTUMNISCHFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012006203-A1 | N-CYCLYL-3 - (CYCLYLCARBONYLAMINOMETHYL) BENZAMIDE DERIVATIVES AS RHO KINASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-01-12 | — | — | WO | disclosed |